Both in Biotechnology
SAB Biotherapeutics vs Scribe Therapeutics
Over the past year SABS returned −1.8% and SCTX returned −48.2%; their daily moves had a correlation of 0.22.
SABS −1.8% SCTX −48.2%Growth of $1, one year, split-adjusted
| Metric | SABS | SCTX |
|---|---|---|
| Price | $3.35 | $15.42 |
| Market cap | $304.8M | $291.9M |
| Today | +3.72% | −11.58% |
| 1 month | +9.5% | −10.2% |
| 6 months | −3.5% | — |
| Year to date | −10.4% | — |
| 1 year | +10.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $99.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | — |
| Short % of float | 6.2% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).